The University of Chicago Header Logo

Connection

Jessica Donington to Middle Aged

Back to Details
This is a "connection" page, showing publications Jessica Donington has written about Middle Aged.
Jessica Donington
Connection Strength
0.620
Middle Aged
  1. Event-free survival as a predictor of overall survival and recurrence burden of patients with non-small cell lung cancer receiving neoadjuvant therapy. J Thorac Cardiovasc Surg. 2024 Oct; 168(4):1261-1269.e1.
    View in: PubMed
    Score: 0.060
  2. 2020 Women in Thoracic Surgery Update on the Status of Women in Cardiothoracic Surgery. Ann Thorac Surg. 2022 03; 113(3):918-925.
    View in: PubMed
    Score: 0.050
  3. Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial. J Intern Med. 2021 04; 289(4):559-573.
    View in: PubMed
    Score: 0.048
  4. STS 2019 Workforce Report: Ad Hoc Analysis of Women in Cardiothoracic Surgery. Ann Thorac Surg. 2021 02; 111(2):383-385.
    View in: PubMed
    Score: 0.048
  5. Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2020 11; 160(5):1331-1345.e1.
    View in: PubMed
    Score: 0.047
  6. Marjolin's Ulcer of the Pleural Surface Within a Long-Standing Eloesser Flap. Ann Thorac Surg. 2016 Nov; 102(5):e383-e385.
    View in: PubMed
    Score: 0.037
  7. The WTS report on the current status of women in cardiothoracic surgery. Ann Thorac Surg. 2012 Aug; 94(2):452-8; discussion 458-9.
    View in: PubMed
    Score: 0.027
  8. Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population. Cancer Biomark. 2012; 12(4):177-84.
    View in: PubMed
    Score: 0.026
  9. Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer. J Clin Oncol. 2010 Feb 20; 28(6):936-41.
    View in: PubMed
    Score: 0.023
  10. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol. 2006 Oct; 1(8):802-9.
    View in: PubMed
    Score: 0.018
  11. Cost effectiveness of commercial portable ex vivo lung perfusion at a low-volume US lung transplant center. Artif Organs. 2024 Nov; 48(11):1288-1296.
    View in: PubMed
    Score: 0.016
  12. Preoperative chemoradiation therapy does not improve early survival after esophagectomy for patients with clinical stage III adenocarcinoma of the esophagus. Ann Thorac Surg. 2004 Apr; 77(4):1193-8; discussion 1198-9.
    View in: PubMed
    Score: 0.015
  13. Pack-Year Smoking History: An Inadequate and Biased Measure to Determine Lung Cancer Screening Eligibility. J Clin Oncol. 2024 Jun 10; 42(17):2026-2037.
    View in: PubMed
    Score: 0.015
  14. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revisions of the T-Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2024 May; 19(5):749-765.
    View in: PubMed
    Score: 0.015
  15. Tumor response to induction chemoradiation: influence on survival after esophagectomy. Eur J Cardiothorac Surg. 2003 Oct; 24(4):631-6; discussion 636-7.
    View in: PubMed
    Score: 0.015
  16. Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma. JAMA Netw Open. 2023 08 01; 6(8):e2327351.
    View in: PubMed
    Score: 0.015
  17. Subsequent pulmonary resection for bronchogenic carcinoma after pneumonectomy. Ann Thorac Surg. 2002 Jul; 74(1):154-8; discussion 158-9.
    View in: PubMed
    Score: 0.014
  18. CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
    View in: PubMed
    Score: 0.013
  19. SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike. mBio. 2021 01 19; 12(1).
    View in: PubMed
    Score: 0.012
  20. Evaluation of the airway microbiome in nontuberculous mycobacteria disease. Eur Respir J. 2018 10; 52(4).
    View in: PubMed
    Score: 0.010
  21. Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839. J Thorac Oncol. 2017 09; 12(9):1413-1420.
    View in: PubMed
    Score: 0.010
  22. An Old Solution for a New Problem: Eloesser Flap Management of Infected Defibrillator Patches. Ann Thorac Surg. 2017 Jun; 103(6):e497-e498.
    View in: PubMed
    Score: 0.010
  23. Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma. J Thorac Oncol. 2016 06; 11(6):900-9.
    View in: PubMed
    Score: 0.009
  24. Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med. 2012 Oct 11; 367(15):1417-27.
    View in: PubMed
    Score: 0.007
  25. A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesth Analg. 2012 Sep; 115(3):694-702.
    View in: PubMed
    Score: 0.007
  26. Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer. Clin Lung Cancer. 2011 Sep; 12(5):280-5.
    View in: PubMed
    Score: 0.006
  27. Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer. J Thorac Oncol. 2011 May; 6(5):920-6.
    View in: PubMed
    Score: 0.006
  28. Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population. J Thorac Oncol. 2010 Oct; 5(10):1649-54.
    View in: PubMed
    Score: 0.006
  29. hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res. 2010 Mar 01; 70(5):1916-24.
    View in: PubMed
    Score: 0.006
  30. Initial experience with endobronchial ultrasound in an academic thoracic surgery program. Clin Lung Cancer. 2010 Jan; 11(1):25-9.
    View in: PubMed
    Score: 0.006
  31. Complications of ablative therapies in lung cancer. Clin Lung Cancer. 2008 Mar; 9(2):122-6.
    View in: PubMed
    Score: 0.005
  32. Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007 Oct 01; 69(2):328-33.
    View in: PubMed
    Score: 0.005
  33. A multidisciplinary approach to management in a patient with bilateral superior sulcus non-small-cell lung carcinoma. Clin Lung Cancer. 2006 Sep; 8(2):146-8.
    View in: PubMed
    Score: 0.005
  34. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res. 2006 Mar 01; 12(5):1507-14.
    View in: PubMed
    Score: 0.004
  35. Case 5--2005: anesthetic management of major hemorrhage during mediastinoscopy. [clin conf]. J Cardiothorac Vasc Anesth. 2005 Oct; 19(5):678-83.
    View in: PubMed
    Score: 0.004
  36. Isolated lung perfusion with tumor necrosis factor for pulmonary metastases. Ann Thorac Surg. 1996 Jun; 61(6):1609-17.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.